The Silent Struggle and Strength Behind Thalassemia’s Smallest
Warriors"
by Dr.Nadipalli Sravani, Consultant Oncologist and Haematologist, Ankura Hospital For Women and Children
A routine evening took
a serious turn for a young couple in their 20s when their three-month-old baby
was noticed to have mild abdominal distension and persistent crying—initially
assumed to be a case of infantile colic. However, upon further evaluation, the
child was diagnosed with Thalassemia Major, a severe inherited blood
disorder that requires lifelong monthly blood transfusions to sustain life.
The family was
informed that although the time commitment involved in transfusions may seem
limited—approximately four hours once a month—the implications of the disease
are far-reaching. Terms such as genetic disorder, lifelong
transfusions, and iron chelation therapy were introduced, leaving
the parents overwhelmed. When the father inquired about a permanent solution, bone
marrow transplantation was presented as the only potential cure—albeit one
associated with complex procedures, significant costs, and a prolonged recovery
timeline.
World Thalassemia Day, observed annually on May 8, is marked to raise awareness about
this chronic hematological condition and to express solidarity with patients
and families affected by it. In Thalassemia Major, the production of
healthy hemoglobin is impaired, resulting in severe anemia. Without regular
treatment, life-threatening complications are inevitable. Thousands of children
in India are diagnosed with this condition each year, making early detection
and consistent management essential.
It is often asked by
parents whether any action of theirs contributed to the diagnosis. It must be
emphasized that no fault lies with the parents, as Thalassemia is a genetic
disorder inherited through carrier status from both parents. Unfortunately,
due to low awareness and insufficient screening, the diagnosis is frequently
made only after symptoms develop.
In such cases, pediatric
hematologists play a critical role. Comprehensive counselling is provided,
followed by the formulation of a tailored treatment plan based on clinical
guidelines. While blood transfusion forms the cornerstone of initial
management, the introduction of iron chelation therapy is vital to
prevent secondary complications such as cardiac failure, liver dysfunction, and
delayed growth. The long-term objective remains to facilitate a healthy transition
into adolescence and adulthood.
It must be stressed
that, with optimal management, children with Thalassemia can experience a normal
and fulfilling childhood. Regular monitoring, adherence to medical
protocols, and a supportive environment are essential components of this
process.
This year’s theme, “Uniting
Communities,” serves as a reminder that comprehensive care must extend
beyond hospitals. The role of communities, support groups, educational
institutions, and policymakers is critical in ensuring that patients have
access to safe and affordable transfusions, psychosocial support, and inclusive
opportunities. Awareness and early screening, particularly premarital and
antenatal, should be promoted as essential public health measures to
prevent the birth of affected children.
On this World
Thalassemia Day, a renewed call is being made for collaborative action—so
that no family is left to navigate this journey alone and every child with
Thalassemia is empowered to lead a life free of limitations.
Comments
Post a Comment